Abstract
In this issue of Blood, Ponce et al report that high suppression of tumorigenicity 2 (ST2) levels are significantly associated with the incidence of acute graft-versus-host disease (aGVHD) and transplant-related mortality (TRM) in recipients of double-unit cord blood transplants (CBTs).
MeSH terms
-
Biomarkers / blood*
-
Cord Blood Stem Cell Transplantation / adverse effects*
-
Female
-
Graft vs Host Disease / diagnosis*
-
Hematologic Neoplasms / mortality*
-
Hematologic Neoplasms / therapy*
-
Humans
-
Interleukin-1 Receptor-Like 1 Protein
-
Male
-
Receptors, Cell Surface / blood*
Substances
-
Biomarkers
-
IL1RL1 protein, human
-
Interleukin-1 Receptor-Like 1 Protein
-
Receptors, Cell Surface